⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for gastrointestinal tumors

Every month we try and update this database with for gastrointestinal tumors cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Study of INCB123667 in Subjects With Advanced Solid TumorsNCT05238922
Solid Tumors
INCB0123667
18 Years - Incyte Corporation
BGT007H Cells for the Treatment of Recurrent/Refractory Gastrointestinal TumorsNCT06152757
Gastrointestina...
First dose
Second dose
The third dose
The fourth dose
18 Years - BioSyngen Pte Ltd
Phase 1 Trial of AZD6422 in CLDN18.2+ GI TumorsNCT05981235
Gastrointestina...
AZD6422 CLDN18....
18 Years - Peking University
Study of Minnelide™ in Patients With Advanced GI TumorsNCT01927965
Advanced Gastro...
Minnelide™ 001
18 Years - Minneamrita Therapeutics LLC
BGT007H Cells for the Treatment of Recurrent/Refractory Gastrointestinal TumorsNCT06152757
Gastrointestina...
First dose
Second dose
The third dose
The fourth dose
18 Years - BioSyngen Pte Ltd
Study of INCB123667 in Subjects With Advanced Solid TumorsNCT05238922
Solid Tumors
INCB0123667
18 Years - Incyte Corporation
Study of INCB123667 in Subjects With Advanced Solid TumorsNCT05238922
Solid Tumors
INCB0123667
18 Years - Incyte Corporation
Application of Multimodal Endoscopic Functional Imaging Technology in the Diagnosis of Common Gastrointestinal DiseasesNCT06236594
Gastrointestina...
18 Years - 80 YearsBeijing 302 Hospital
Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal TumorsNCT01640665
Metastatic Brea...
Gastrointestina...
Sorafenib
Capecitabine
18 Years - Yale University
Phase II Study of Reuse of Oxaliplatin Hypersensitivity in Gastrointestinal TumorsNCT05922358
Gastrointestina...
Anti-allergic t...
18 Years - 75 YearsFujian Cancer Hospital
Effects of Immunonutrition on the Improvement of Postoperative Adjuvant Chemotherapy Related Adverse Reactions in Patients With Gastrointestinal TumorsNCT06085365
Gastrointestina...
Immunonutrition
Postoperative A...
Immunonutrition...
fluorouracil ba...
18 Years - 75 YearsChina Medical University, China
Phase 1 Trial of AZD6422 in CLDN18.2+ GI TumorsNCT05981235
Gastrointestina...
AZD6422 CLDN18....
18 Years - Peking University
Wound Management Following Gl Tumor Surgery: Comparing Outcomes of Dressing Changes Versus Non-Dressing TechniquesNCT06263205
Gastrointestina...
Surgical Wound ...
Pain, Postopera...
Non-Dressing of...
Regular Dressin...
18 Years - 75 YearsFudan University
The Impact of Preoperative Oral Glutamine Intake on the Immunocompetence and Outcomes of Malnourished Patients Undergoing Major Abdominal Surgery Due to MalignanciesNCT01552291
Malnourishment
Gastrointestina...
Glutamine
Placebo
- Insel Gruppe AG, University Hospital Bern
Study of Everolimus Treatment in Newly-diagnosed Patients With Advanced Gastrointestinal Neuroendocrine TumorsNCT01648465
Gastrointestina...
Pancreatic Tumo...
Gastrointestina...
Pancreatic Neur...
Everolimus
18 Years - Hellenic Cooperative Oncology Group
Phase II Study of Reuse of Oxaliplatin Hypersensitivity in Gastrointestinal TumorsNCT05922358
Gastrointestina...
Anti-allergic t...
18 Years - 75 YearsFujian Cancer Hospital
A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)NCT03833700
Solid Neoplasms
Colorectal Neop...
Gastrointestina...
E7386
18 Years - Eisai Inc.
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: